{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:27:27Z","timestamp":1791214047680,"version":"4.1.0"},"reference-count":137,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,10]],"date-time":"2014-12-10T00:00:00Z","timestamp":1418169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.bbadis.2014.09.005","type":"journal-article","created":{"date-parts":[[2014,9,18]],"date-time":"2014-09-18T20:21:11Z","timestamp":1411071671000},"page":"633-643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["Sporadic inclusion-body myositis: A degenerative muscle disease associated with aging, impaired muscle protein homeostasis and abnormal mitophagy"],"prefix":"10.1016","volume":"1852","author":[{"given":"Valerie","family":"Askanas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. King","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nogalska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2014.09.005_bb0005","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/BOR.0b013e3282efdc7c","article-title":"Inclusion-body myositis, a multifactorial muscle disease associated with aging: current concepts of pathogenesis","volume":"19","author":"Askanas","year":"2007","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0010","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00401-008-0449-0","article-title":"Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer's and Parkinson's disease brains","volume":"116","author":"Askanas","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0015","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1750-3639.2009.00290.x","article-title":"Inclusion body myositis: a degenerative muscle disease associated with intra-muscle fiber multi-protein aggregates, proteasome inhibition, endoplasmic reticulum stress and decreased lysosomal degradation","volume":"19","author":"Askanas","year":"2009","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0020","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1212\/01.wnl.0000192260.33106.bb","article-title":"Inclusion-body myositis: clinical, diagnostic, and pathologic aspects","volume":"66","author":"Engel","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0025","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1212\/01.wnl.0000192128.13875.1e","article-title":"Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition","volume":"66","author":"Askanas","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0030","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.nmd.2005.01.012","article-title":"Allelic heterogeneity of GNE gene mutation in two Tunisian families with autosomal recessive inclusion body myopathy","volume":"15","author":"Amouri","year":"2005","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0035","series-title":"The Molecular and Genetic Basis of Neurologic and Psychiatric Disease","first-page":"524","article-title":"Hereditary inclusion body myopathies","author":"Askanas","year":"2008"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0040","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0960-8966(03)00140-8","article-title":"A novel homozygous missense mutation in the GNE gene of a patient with quadriceps-sparing hereditary inclusion body myopathy associated with muscle inflammation","volume":"13","author":"Krause","year":"2003","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0045","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00019052-200210000-00002","article-title":"Inclusion-body myositis and myopathies: different etiologies, possibly similar pathogenic mechanisms","volume":"15","author":"Askanas","year":"2002","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0050","doi-asserted-by":"crossref","first-page":"11125","DOI":"10.1073\/pnas.0811753106","article-title":"Secretion of amyloidogenic gelsolin progressively compromises protein homeostasis leading to the intracellular aggregation of proteins","volume":"106","author":"Page","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrrheum.2010.2","article-title":"Immunotherapy of myositis: issues, concerns and future prospects","volume":"6","author":"Dalakas","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0060","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1093\/brain\/awr213","article-title":"Long-term observational study of sporadic inclusion body myositis","volume":"134","author":"Benveniste","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0065","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11910-012-0321-4","article-title":"Inclusion body myositis","volume":"13","author":"Dimachkie","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0070","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2990.2010.01153.x","article-title":"Review: an update on inflammatory and autoimmune myopathies","volume":"37","author":"Dalakas","year":"2011","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0075","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1586\/1744666X.2013.842467","article-title":"Inclusion body myositis: from immunopathology and degenerative mechanisms to treatment perspectives","volume":"9","author":"Schmidt","year":"2013","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0080","series-title":"Muscle aging, inclusion-body myositis and myopathies","first-page":"146","article-title":"Inflammatory and autoimmune features of inclusion-body myositis","author":"Dalakas","year":"2012"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0085","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jneuroim.2012.05.003","article-title":"High-resolution HLA-DRB1 genotyping in an Australian inclusion body myositis (s-IBM) cohort: an analysis of disease-associated alleles and diplotypes","volume":"250","author":"Rojana-udomsart","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0090","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.nmd.2013.09.008","article-title":"Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms","volume":"23","author":"Mastaglia","year":"2013","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0095","doi-asserted-by":"crossref","first-page":"13145","DOI":"10.1073\/pnas.0806192105","article-title":"The amyloid \u03b2-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae","volume":"105","author":"Hansson Petersen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0100","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/510026a","article-title":"Alzheimer's disease: the forgetting gene","volume":"510","author":"Spinney","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0105","series-title":"Muscle aging, inclusion-body myositis and myopathies","first-page":"159","article-title":"Sporadic inclusion-body myositis: clinical symptoms, physical findings, and diagnostic investigations","author":"Mastaglia","year":"2012"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0110","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jneuroim.2012.04.007","article-title":"Frequency of autoantibodies and correlation with HLA-DRB1 genotype in sporadic inclusion body myositis (s-IBM): a population control study","volume":"249","author":"Rojana-udomsart","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0115","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ana.23840","article-title":"Cytosolic 5\u2032-nucleotidase 1A autoimmunity in sporadic inclusion body myositis","volume":"73","author":"Larman","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0120","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ana.23822","article-title":"Autoantibodies to cytosolic 5\u2032-nucleotidase 1A in inclusion body myositis","volume":"73","author":"Pluk","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0125","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/NEN.0b013e31826183c8","article-title":"Pathogenic considerations in sporadic inclusion-body myositis, a degenerative muscle disease associated with aging and abnormalities of myoproteostasis","volume":"71","author":"Askanas","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0130","series-title":"Muscle Ageing","first-page":"111","article-title":"Pathogenesis of sporadic inclusion-body myositis; role of ageing and muscle-fibre degeneration, and accumulation of the same proteins as in Alzheimer and Parkinson brains","author":"Askanas","year":"2012"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0135","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1016\/j.lpm.2010.11.024","volume":"40","author":"Askanas","year":"2011","journal-title":"Presse Med."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0140","doi-asserted-by":"crossref","first-page":"16995","DOI":"10.1073\/pnas.0603386103","article-title":"MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle","volume":"103","author":"Morosetti","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0145","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.ajpath.2011.12.027","article-title":"TWEAK in inclusion-body myositis muscle: possible pathogenic role of a cytokine inhibiting myogenesis","volume":"180","author":"Morosetti","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0150","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.nmd.2014.04.009","article-title":"Four-year longitudinal study of clinical and functional endpoints in sporadic inclusion body myositis: implications for therapeutic trials","volume":"24","author":"Hogrel","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0155","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00401-009-0554-8","article-title":"Increased plasma amyloid-beta42 protein in sporadic inclusion body myositis","volume":"118","author":"Abdo","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0160","doi-asserted-by":"crossref","first-page":"e004552","DOI":"10.1136\/bmjopen-2013-004552","article-title":"A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis","volume":"4","author":"Brady","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0165","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/cbic.201200731","article-title":"Luminescent conjugated oligothiophenes for sensitive fluorescent assignment of protein inclusion bodies","volume":"14","author":"Klingstedt","year":"2013","journal-title":"Chembiochem"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0170","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1212\/01.wnl.0000192127.63013.8d","article-title":"Mitochondrial abnormalities in inclusion-body myositis","volume":"66","author":"Oldfors","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0175","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/jnnp.2007.131334","article-title":"TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia","volume":"79","author":"Weihl","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0180","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/NEN.0b013e3181996d8f","article-title":"TAR DNA-binding protein 43 accumulation in protein aggregate myopathies","volume":"68","author":"Olive","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0185","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2990.2010.01108.x","article-title":"In sporadic inclusion-body myositis muscle fibres TDP-43-positive inclusions are less frequent and robust than p62-inclusions, and are not associated with paired helical filaments","volume":"37","author":"D'Agostino","year":"2011","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0190","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1750-3639.2009.00326.x","article-title":"Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates","volume":"20","author":"Martinez","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0195","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.freeradbiomed.2008.05.030","article-title":"In inclusion-body myositis muscle fibers Parkinson-associated DJ-1 is increased and oxidized","volume":"45","author":"Terracciano","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0200","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00001756-199612200-00031","article-title":"Increase of nitric oxide synthases and nitrotyrosine in inclusion-body myositis","volume":"8","author":"Yang","year":"1996","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0205","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1021\/bi047982v","article-title":"Site-specific nitration and oxidative dityrosine bridging of the tau protein by peroxynitrite: implications for Alzheimer's disease","volume":"44","author":"Reynolds","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0210","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1016\/j.febslet.2005.03.041","article-title":"Nitration and oligomerization of tau induced by peroxynitrite inhibit its microtubule-binding activity","volume":"579","author":"Zhang","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0215","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1212\/01.wnl.0000192261.02023.b8","article-title":"Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting","author":"Ciechanover","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0220","doi-asserted-by":"crossref","first-page":"718","DOI":"10.2741\/2714","article-title":"The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy","volume":"13","author":"Shacka","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0225","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.tig.2008.10.002","article-title":"Autophagy and aging: keeping that old broom working","volume":"24","author":"Cuervo","year":"2008","journal-title":"Trends Genet."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0230","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1083\/jcb.201005144","article-title":"Protein homeostasis and aging in neurodegeneration","volume":"190","author":"Douglas","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0235","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2014.03.007","article-title":"Differential scales of protein quality control","volume":"157","author":"Wolff","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0240","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00001756-199306000-00055","article-title":"beta-Amyloid precursor protein mRNA is increased in inclusion-body myositis muscle","volume":"4","author":"Sarkozi","year":"1993","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0245","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/0006-291X(89)92760-5","article-title":"Tissue-specific expression of three types of beta-protein precursor mRNA: enhancement of protease inhibitor-harboring types in Alzheimer's disease brain","volume":"165","author":"Tanaka","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0250","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1471-4159.2009.06461.x","article-title":"In AbetaPP-overexpressing cultured human muscle fibers proteasome inhibition enhances phosphorylation of AbetaPP751 and GSK3beta activation: effects mitigated by lithium and apparently relevant to sporadic inclusion-body myositis","volume":"112","author":"Terracciano","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0255","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neulet.2010.03.023","article-title":"Increased BACE1 mRNA and noncoding BACE1-antisense transcript in sporadic inclusion-body myositis muscle fibers\u2014possibly caused by endoplasmic reticulum stress","volume":"474","author":"Nogalska","year":"2010","journal-title":"Neurosci. Lett."},{"issue":"Suppl. 1","key":"10.1016\/j.bbadis.2014.09.005_bb0260","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1471-4159.2011.07515.x","article-title":"Regulation of beta-site APP-cleaving enzyme 1 gene expression and its role in Alzheimer's disease","volume":"120","author":"Sun","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0265","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nm1784","article-title":"Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase","volume":"14","author":"Faghihi","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0270","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cell.2014.03.008","article-title":"The noncoding RNA revolution-trashing old rules to forge new ones","volume":"157","author":"Cech","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0275","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.nbd.2012.06.008","article-title":"Activation of the gamma-secretase complex and presence of gamma-secretase-activating protein may contribute to Abeta42 production in sporadic inclusion-body myositis muscle fibers","volume":"48","author":"Nogalska","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0280","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-cellbio-100109-104117","article-title":"Novel research horizons for presenilins and gamma-secretases in cell biology and disease","volume":"26","author":"De Strooper","year":"2010","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0285","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ana.410340408","article-title":"Beta-amyloid precursor epitopes in muscle fibers of inclusion body myositis","volume":"34","author":"Askanas","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0290","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/0140-6736(92)90388-J","article-title":"beta-Amyloid protein immunoreactivity in muscle of patients with inclusion-body myositis","volume":"339","author":"Askanas","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0295","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0002-9440(10)65680-5","article-title":"Does overexpression of betaAPP in aging muscle have a pathogenic role and a relevance to Alzheimer's disease? Clues from inclusion body myositis, cultured human muscle, and transgenic mice","volume":"153","author":"Askanas","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0300","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nm.2460","article-title":"Resolving controversies on the path to Alzheimer's therapeutics","volume":"17","author":"Selkoe","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0305","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrn2168","article-title":"Intracellular amyloid-beta in Alzheimer's disease","volume":"8","author":"LaFerla","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"issue":"Suppl. 1","key":"10.1016\/j.bbadis.2014.09.005_bb0310","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1471-4159.2011.07478.x","article-title":"Soluble Abeta oligomer production and toxicity","volume":"120","author":"Larson","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0315","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00401-009-0511-6","article-title":"Amyloid-beta42 is preferentially accumulated in muscle fibers of patients with sporadic inclusion-body myositis","volume":"117","author":"Vattemi","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0320","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00401-013-1186-6","article-title":"Dysferlin is a newly identified binding partner of A\u03b2PP and it co-aggregates with amyloid-\u03b242 within sporadic inclusion-body myositis (s-IBM) muscle fibers","volume":"126","author":"Cacciottolo","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0325","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2119\/molmed.2011.00084","article-title":"Translational research and therapeutic perspectives in dysferlinopathies","volume":"17","author":"Barth\u00e9l\u00e9my","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0330","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00401-010-0737-3","article-title":"Novel demonstration of amyloid-beta oligomers in sporadic inclusion-body myositis muscle fibers","volume":"120","author":"Nogalska","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0335","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.neurobiolaging.2004.02.010","article-title":"Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease","volume":"25","author":"Klein","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0340","series-title":"Peroneal Atrophies and Related Disorders","first-page":"333","article-title":"Plasma-cell dyscrasic amyloid neuropathy: A parasparafucile phenomenon?","author":"Engel","year":"1979"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0345","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3233\/JAD-2008-14409","article-title":"Tau aggregation and toxicity in tauopathic neurodegenerative diseases","volume":"14","author":"Honson","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0350","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00401-009-0486-3","article-title":"Mechanisms of tau-induced neurodegeneration","volume":"118","author":"Iqbal","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0355","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/00005072-199607000-00003","article-title":"Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies","volume":"55","author":"Mirabella","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0360","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00401-009-0564-6","article-title":"p62\/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis","volume":"118","author":"Nogalska","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0365","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1046\/j.1471-4159.1997.69052087.x","article-title":"A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease","volume":"69","author":"Jicha","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0370","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neulet.2011.08.042","article-title":"Novel demonstration of conformationally-modified tau in sporadic inclusion-body myositis muscle fibers","volume":"503","author":"Nogalska","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0375","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neulet.2007.11.066","article-title":"Casein kinase 1 alpha associates with the tau-bearing lesions of inclusion body myositis","volume":"431","author":"Kannanayakal","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0380","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0002-9440(10)64983-8","article-title":"Paired helical filaments of inclusion-body myositis muscle contain RNA and survival motor neuron protein","volume":"156","author":"Broccolini","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0385","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tins.2008.11.007","article-title":"Tau pathophysiology in neurodegeneration: a tangled issue","volume":"32","author":"Spires-Jones","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0390","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.neuron.2010.08.044","article-title":"Acetylation of tau inhibits its degradation and contributes to tauopathy","volume":"67","author":"Min","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0395","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1093\/hmg\/ddp367","article-title":"Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing","volume":"18","author":"Wang","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0400","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9440(10)62994-X","article-title":"Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in AbPP-overexpressing cultured human muscle fibers","volume":"167","author":"Fratta","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0405","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.2353\/ajpath.2010.100050","article-title":"Impaired autophagy in sporadic inclusion-body myositis and in endoplasmic reticulum stress-provoked cultured human muscle fibers","volume":"177","author":"Nogalska","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0410","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0415","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.mco.0000134365.99523.7f","article-title":"Role of myostatin in metabolism","volume":"7","author":"Gonzalez-Cadavid","year":"2004","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0420","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00401-005-1035-3","article-title":"Myostatin is increased and complexes with amyloid-beta within sporadic inclusion-body myositis muscle fibers","volume":"110","author":"Wojcik","year":"2005","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0425","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2990.2006.00821.x","article-title":"Myostatin precursor protein is increased and associates with amyloid-beta precursor protein in inclusion-body myositis culture model","volume":"33","author":"Wojcik","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0430","doi-asserted-by":"crossref","first-page":"e9170","DOI":"10.1371\/journal.pone.0009170","article-title":"Cytotoxic aggregation and amyloid formation by the myostatin precursor protein","volume":"5","author":"Starck","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0435","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s12640-009-9073-6","article-title":"Role of synucleins in Alzheimer's disease","volume":"16","author":"Crews","year":"2009","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0440","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1002\/mds.23948","article-title":"Parkinson's disease and alpha-synuclein expression","volume":"26","author":"Devine","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0445","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/jnen\/59.7.592","article-title":"Novel immunolocalization of alpha-synuclein in human muscle of inclusion-body myositis, regenerating and necrotic muscle fibers, and at neuromuscular junctions","volume":"59","author":"Askanas","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0450","first-page":"13","article-title":"Parkin and its association with alpha-synuclein and AbetaPP in inclusion-body myositis and AbetaPP-overexpressing cultured human muscle fibers","volume":"25","author":"Paciello","year":"2006","journal-title":"Acta Myol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0455","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/path.3025","article-title":"Autophagy and disease: always two sides to a problem","volume":"226","author":"Sridhar","year":"2012","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0460","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/nan.12038","article-title":"Chaperone-mediated autophagy components are upregulated in sporadic inclusion-body myositis muscle fibres","volume":"39","author":"Cacciottolo","year":"2013","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0465","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbadis.2009.07.007","article-title":"Mitochondrial trafficking of APP and alpha synuclein: relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases","volume":"1802","author":"Devi","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0470","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1111\/j.1742-4658.2011.08389.x","article-title":"Stimulatory effect of alpha-synuclein on the tau-phosphorylation by GSK-3beta","volume":"278","author":"Kawakami","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0475","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nbd.2011.01.021","article-title":"Autophagy failure in Alzheimer's disease-locating the primary defect","volume":"43","author":"Nixon","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0480","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1212\/01.WNL.0000138574.56908.5D","article-title":"Mutant ubiquitin UBB+1 is accumulated in sporadic inclusion-body myositis muscle fibers","volume":"63","author":"Fratta","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0485","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00401-009-0560-x","article-title":"The ubiquitin proteasome system in neuropathology","volume":"118","author":"Lehman","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0490","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nm.3232","article-title":"The role of autophagy in neurodegenerative disease","volume":"19","author":"Nixon","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0495","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1159\/000351979","article-title":"The mechanism and physiological function of macroautophagy","volume":"5","author":"Klionsky","year":"2013","journal-title":"J. Innate. Immun."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0500","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1460-9568.2008.06084.x","article-title":"Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression","volume":"27","author":"Hamano","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0505","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuron.2006.07.027","article-title":"Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease","volume":"51","author":"Mueller-Steiner","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0510","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1083\/jcb.200505082","article-title":"Macroautophagy\u2014a novel beta-amyloid peptide-generating pathway activated in Alzheimer's disease","volume":"171","author":"Yu","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0515","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1083\/jcb.200507002","article-title":"p62\/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death","volume":"171","author":"Bjorkoy","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0520","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.molcel.2009.01.020","article-title":"A role for NBR1 in autophagosomal degradation of ubiquitinated substrates","volume":"33","author":"Kirkin","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0525","doi-asserted-by":"crossref","first-page":"8055","DOI":"10.1128\/MCB.24.18.8055-8068.2004","article-title":"Sequestosome 1\/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation","volume":"24","author":"Seibenhener","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0530","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00401-011-0874-3","article-title":"Abnormalities of NBR1, a novel autophagy-associated protein, in muscle fibers of sporadic inclusion-body myositis","volume":"122","author":"D'Agostino","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0535","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.1365-2990.2002.00394.x","article-title":"Early accumulation of p62 in neurofibrillary tangles in Alzheimer's disease: possible role in tangle formation","volume":"28","author":"Kuusisto","year":"2002","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0540","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.4161\/auto.28479","article-title":"Phosphorylation of NBR1 by GSK3 modulates protein aggregation","volume":"10","author":"Nicot","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0545","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0002-9440(10)65056-0","article-title":"Association of active extracellular signal-regulated protein kinase with paired helical filaments of inclusion-body myositis muscle suggests its role in inclusion-body myositis tau phosphorylation","volume":"156","author":"Wilczynski","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0550","article-title":"\u201cRagged-red fibers\u201d in opthamoplegia syndromes and their differential diagnosis","volume":"237","author":"Engel","year":"1971","journal-title":"Excerpta Med. Int. Congr. Ser."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0555","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.embor.7400074","article-title":"DJ-1 has a role in antioxidative stress to prevent cell death","volume":"5","author":"Taira","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0560","article-title":"Mitochondrial and inflammatory changes in sporadic inclusion body myositis","author":"Rygiel","year":"2014","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0565","first-page":"A304","article-title":"In sporadic inclusion-body myositis muscle biopsies, cytochrome oxidase (COX) negative muscle fibers do not correlate with either inflammation or with aggregates containing amyloid-beta or phosphorylated tau","volume":"70","author":"Terracciano","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0570","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1253\/circj.CJ-13-0835","article-title":"Mitochondrial autophagy\u2014an essential quality control mechanism for myocardial homeostasis","volume":"77","author":"Thomas","year":"2013","journal-title":"Circ. J."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0575","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.exger.2014.01.021","article-title":"Mitochondrial homeostasis: the interplay between mitophagy and mitochondrial biogenesis","volume":"56","author":"Palikaras","year":"2014","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0580","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/cdd.2012.81","article-title":"The pathways of mitophagy for quality control and clearance of mitochondria","volume":"20","author":"Ashrafi","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0585","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1515\/hsz-2012-0119","article-title":"Mitophagy: mechanisms, pathophysiological roles, and analysis","volume":"393","author":"Ding","year":"2012","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0590","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.nbd.2010.09.009","article-title":"Mitochondrial autophagy in neural function, neurodegenerative disease, neuron cell death, and aging","volume":"43","author":"Batlevi","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0595","doi-asserted-by":"crossref","first-page":"19094","DOI":"10.1074\/jbc.M111.322933","article-title":"Microtubule-associated protein 1 light chain 3 (LC3) interacts with Bnip3 protein to selectively remove endoplasmic reticulum and mitochondria via autophagy","volume":"287","author":"Hanna","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0600","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00401-011-0921-0","article-title":"Neurodegeneration as a consequence of failed mitochondrial maintenance","volume":"123","author":"Karbowski","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0605","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1042\/bse0550093","article-title":"Mitophagy","volume":"55","author":"MacVicar","year":"2013","journal-title":"Essays Biochem."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0610","doi-asserted-by":"crossref","first-page":"P3.288","DOI":"10.1212\/WNL.82.10_supplement.P3.288","article-title":"Abnormalities of mitophagy in sporadic inclusion-body myositis (s-IBM) muscle fibers","volume":"82","author":"Nogalska","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0615","doi-asserted-by":"crossref","first-page":"e99937","DOI":"10.1371\/journal.pone.0099937","article-title":"Mutant ubiquitin UBB+1 induces mitochondrial fusion by destabilizing mitochondrial fission-specific proteins and confers resistance to oxidative stress-induced cell death in astrocytic cells","volume":"9","author":"Yim","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0620","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1242\/jeb.090738","article-title":"The mitochondrial unfolded protein response, a conserved stress response pathway with implications in health and disease","volume":"217","author":"Jovaisaite","year":"2014","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0625","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.2174\/092986711798347315","article-title":"Defining the mechanism of action of 4-phenylbutyrate to develop a small-molecule-based therapy for Alzheimer's disease","volume":"18","author":"Cuadrado-Tejedor","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0630","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2165\/11591280-000000000-00000","article-title":"Clinical and experimental applications of sodium phenylbutyrate","volume":"11","author":"Iannitti","year":"2011","journal-title":"Drugs R D"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0635","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/3-540-29717-0_16","article-title":"Chemical chaperones: mechanisms of action and potential use","author":"Papp","year":"2006","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0640","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.nbd.2014.01.012","article-title":"Sodium phenylbutyrate reverses lysosomal dysfunction and decreases amyloid-beta42 in an in vitro-model of inclusion-body myositis","volume":"65","author":"Nogalska","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0645","doi-asserted-by":"crossref","first-page":"788","DOI":"10.4161\/auto.7.7.15596","article-title":"Therapeutic effects of remediating autophagy failure in a mouse model of Alzheimer disease by enhancing lysosomal proteolysis","volume":"7","author":"Yang","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0650","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000113715","article-title":"Lithium, a potential protective drug in Alzheimer's disease","volume":"5","author":"Engel","year":"2008","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0655","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ana.21325","article-title":"Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase-3beta","volume":"64","author":"Kitazawa","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0660","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.4161\/cc.6.20.4815","article-title":"Resveratrol: from basic science to the clinic","volume":"6","author":"Cucciolla","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbadis.2014.09.005_bb0665","first-page":"S9","article-title":"Resveratrol, a polyphenol found in red wine, reduces NF-kB-activation and myostatin in endoplasmic-reticulum-stress (ERS)-provoked cultured human muscle fibers (CHMFs): relevance to treatment of sporadic inclusion-body myositis (s-IBM)","volume":"64","author":"Nogalska","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0670","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.2353\/ajpath.2009.090417","article-title":"Phenolic compounds prevent Alzheimer's pathology through different effects on the amyloid-beta aggregation pathway","volume":"175","author":"Hamaguchi","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0675","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/joim.12168","article-title":"Amyloid-\u03b2-directed immunotherapy for Alzheimer disease","volume":"275","author":"Lannfelt","year":"2014","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0680","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/ITT.S31428","article-title":"Anti-amyloid-beta to tau-based immunization: Developmetnin immunotherapy for Alzheimer disease","volume":"2","author":"Lambracht-Washington","year":"2013","journal-title":"Immunotargets Ther."},{"key":"10.1016\/j.bbadis.2014.09.005_bb0685","first-page":"1","article-title":"\u03b2-secretase inhibitor; a promising novel therapeutic drug in Alzheimer disease","volume":"6","author":"Willmijn Menting","year":"2014","journal-title":"Front. Aging Neurosci."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443914002865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443914002865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T17:46:45Z","timestamp":1717350405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443914002865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":137,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0925443914002865"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2014.09.005","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sporadic inclusion-body myositis: A degenerative muscle disease associated with aging, impaired muscle protein homeostasis and abnormal mitophagy","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2014.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}